Immediate Impact
1 from Science/Nature 61 standout
Citing Papers
The hallmarks of cancer immune evasion
2024 Standout
Metabolic reprogramming in the tumor microenvironment of liver cancer
2024 Standout
Works of Liewen Jiang being referenced
Final results from ClarIDHy, a global, phase III, randomized, double-blind study of ivosidenib (IVO) versus placebo (PBO) in patients (pts) with previously treated cholangiocarcinoma (CCA) and an isocitrate dehydrogenase 1 (IDH1) mutation.
2021
Phase I Study of the Mutant IDH1 Inhibitor Ivosidenib: Safety and Clinical Activity in Patients With Advanced Chondrosarcoma
2020
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| Liewen Jiang | 201 | 147 | 117 | 143 | 19 | 472 | |
| Edem Agamah | 98 | 170 | 115 | 146 | 16 | 542 | |
| J.C. Sabourin | 92 | 136 | 37 | 168 | 16 | 535 | |
| Péter Riesz | 261 | 64 | 216 | 133 | 34 | 498 | |
| James E. Bruckman | 157 | 144 | 97 | 170 | 16 | 528 | |
| Kolette D. Fly | 66 | 175 | 71 | 230 | 15 | 449 | |
| Martina Crysandt | 47 | 165 | 56 | 135 | 42 | 484 | |
| Francesca Garbini | 73 | 150 | 53 | 96 | 26 | 507 | |
| Gregory Gagnon | 140 | 182 | 78 | 208 | 15 | 546 | |
| H Chapuis | 115 | 122 | 76 | 105 | 25 | 516 | |
| Waheed Sangrar | 220 | 86 | 177 | 58 | 23 | 571 |
All Works
Loading papers...